Srivastava et al. [61] have found that patients with MMP2 (-1306) CT genotype as well as T allele were at higher risk of prostate cancer (p = 0.018; OR = 1.68 and p = 0.015; OR = 1.52). The gene discussed is MMP2; the disease is prostate carcinoma.